Rittenhouse Media

Funding growth of leading digital medical library


Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9



Rittenhouse is the nation's largest specialized distributor of print and digital health science information. We bring more than 75 years of industry experience and $38MM+ in revenues.

We are investing in MACH technology: Microservices-based, API-first, Cloud-native, and Headless-development, to grow to a $20 million digital business with 35-40% gross margins by 2025.

Rittenhouse Strengths:

  • A single source for vetted, trusted, peer reviewed information.
  • Unique, sole-source relationships with health sciences scholarly and association publishers.
  • With 76-year history, we are well-known and trusted by the industry. 
  • Proven long-term viability in a turbulent marketplace.


A quick Google search of any medical term can yield billions of results, and a majority of them are unhelpful, irrelevant and unvetted. This is known as the Dr. Google effect.

Many professionals and health care systems have relevant, vetted research and information that needs a single source of access.  Rittenhouse Digital will be this sole source.


Rittenhouse Digital leverages the industry-standard medical thesaurus, MESH from the National Library of Medicine, to create a powerful, topic-driven database that delivers more relevant, more accurate search results.

More than eBooks, the Rittenhouse Digital database will ingest powerful health sciences information to expand research, learning and consumer databases. Specialized libraries and databases will be accessed or ingested via API based on the need of the client.

The re-launch of the R2 Digital Library will feature the latest MACH technologies, paving the way for future development. Publishing and customer partnerships will be leveraged to develop new and exciting products.

The platform will be offered as an easy-to-use app and website with capacity for white labeling.


Rittenhouse Digital streamlines content ingestion with a proprietary tool that tags topic-driven terms to make ePub documents searchable. Our powerful search engine will cross-reference medical terms to normalize disparate types of information.  

The Rittenhouse ingestion engine reduces costs  for our publishing partners and enables access to high-quality scientific, technical and medial materials.  We bring together content from multiple sources in one powerful database.


Our new R2 Digital Library is under development:
The relaunch of a New R2 Digital Library is scheduled for Q4-2022. With this platform we expect to grow our $1.8 million digital business to $20 million in three years.

Our strategic partners are the industry leaders in health science education and healthcare:

  • Follett manages 1800 on-campus & virtual college bookstores.
  • Lippincott is the largest publisher of health science textbooks.
  • FA Davis is the largest publisher of nursing textbooks.
  • Kaiser, Ascension and many other health care systems currently subscribe to our digital products

Our company is a respected industry veteran with broad reach:
We represent about 500 publishers worldwide selling to colleges, universities, healthcare systems and governments.


The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.

Request Access


No updates yet.


No backers yet.

Quick Signup TBD

You must have an account to do this!

the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.